1h Free Analyst Time
The publisher has been monitoring the rapid diagnostics market and it is poised to grow by $12.74 bn during 2022-2026 progressing at a CAGR of 7.58% during the forecast period. The report on the rapid diagnostics market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of chronic and infectious diseases, focus on innovative rapid diagnostics and increasing product approvals, and increasing funding for rapid diagnostics products.
The rapid diagnostics market analysis includes the application segment and geographic landscape.
The rapid diagnostics market is segmented as below:
By Application
- Blood glucose
- Infectious disease
- Cardiometabolic
- Pregnancy and fertility
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing presence of OEMs as one of the prime reasons driving the rapid diagnostics market growth during the next few years. Also, the use of digital health in rapid diagnostics for POC and an increasing number of m and a will lead to sizable demand in the market.
The report on the rapid diagnostics market covers the following areas:
- Rapid diagnostics market sizing
- Rapid diagnostics market forecast
- Rapid diagnostics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading rapid diagnostics market vendors that include Abbott Laboratories, Atomo Diagnostics Ltd., Becton Dickinson and Co., bioMerieux SA, Cardinal Health Inc., Chembio Diagnostics Inc., DAAN Gene Co. Ltd., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GlySens Inc., Johnson, and Johnson, Meridian Bioscience Inc., NanoRepro AG, Quidel Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech Plc, Wuhan EasyDiagnosis Biomedicine Co. Ltd, and OraSure Technologies Inc. Also, the rapid diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Blood glucose - Market size and forecast 2021-2026
Exhibit 28: Chart on Blood glucose - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Blood glucose - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Blood glucose - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Blood glucose - Year-over-year growth 2021-2026 (%)
5.4 Infectious disease - Market size and forecast 2021-2026
Exhibit 32: Chart on Infectious disease - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Infectious disease - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Infectious disease - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Infectious disease - Year-over-year growth 2021-2026 (%)
5.5 Cardiometabolic - Market size and forecast 2021-2026
Exhibit 36: Chart on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Cardiometabolic - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Cardiometabolic - Year-over-year growth 2021-2026 (%)
5.6 Pregnancy and fertility - Market size and forecast 2021-2026
Exhibit 40: Chart on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
5.7 Others - Market size and forecast 2021-2026
Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.8 Market opportunity by Application
Exhibit 48: Market opportunity by Application ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 52: Chart on Geographic comparison
Exhibit 53: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Japan - Market size and forecast 2021-2026
Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 France - Market size and forecast 2021-2026
Exhibit 90: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 91: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 92: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 93: Data Table on France - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 94: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 95: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 96: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 97: Overview on factors of disruption
9.4 Industry risks
Exhibit 98: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 99: Vendors covered
10.2 Market positioning of vendors
Exhibit 100: Matrix on vendor position and classification
10.3 Abbott Laboratories
Exhibit 101: Abbott Laboratories - Overview
Exhibit 102: Abbott Laboratories - Business segments
Exhibit 103: Abbott Laboratories - Key news
Exhibit 104: Abbott Laboratories - Key offerings
Exhibit 105: Abbott Laboratories - Segment focus
10.4 Atomo Diagnostics Ltd.
Exhibit 106: Atomo Diagnostics Ltd. - Overview
Exhibit 107: Atomo Diagnostics Ltd. - Product / Service
Exhibit 108: Atomo Diagnostics Ltd. - Key offerings
10.5 Becton Dickinson and Co.
Exhibit 109: Becton Dickinson and Co. - Overview
Exhibit 110: Becton Dickinson and Co. - Business segments
Exhibit 111: Becton Dickinson and Co. - Key news
Exhibit 112: Becton Dickinson and Co. - Key offerings
Exhibit 113: Becton Dickinson and Co. - Segment focus
10.6 bioMerieux SA
Exhibit 114: bioMerieux SA - Overview
Exhibit 115: bioMerieux SA - Business segments
Exhibit 116: bioMerieux SA - Key offerings
Exhibit 117: bioMerieux SA - Segment focus
10.7 Cardinal Health Inc.
Exhibit 118: Cardinal Health Inc. - Overview
Exhibit 119: Cardinal Health Inc. - Business segments
Exhibit 120: Cardinal Health Inc. - Key news
Exhibit 121: Cardinal Health Inc. - Key offerings
Exhibit 122: Cardinal Health Inc. - Segment focus
10.8 Chembio Diagnostics Inc.
Exhibit 123: Chembio Diagnostics Inc. - Overview
Exhibit 124: Chembio Diagnostics Inc. - Product / Service
Exhibit 125: Chembio Diagnostics Inc. - Key offerings
10.9 Danaher Corp.
Exhibit 126: Danaher Corp. - Overview
Exhibit 127: Danaher Corp. - Business segments
Exhibit 128: Danaher Corp. - Key news
Exhibit 129: Danaher Corp. - Key offerings
Exhibit 130: Danaher Corp. - Segment focus
10.10 F. Hoffmann La Roche Ltd.
Exhibit 131: F. Hoffmann La Roche Ltd. - Overview
Exhibit 132: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 133: F. Hoffmann La Roche Ltd. - Key news
Exhibit 134: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 135: F. Hoffmann La Roche Ltd. - Segment focus
10.11 Johnson and Johnson
Exhibit 136: Johnson and Johnson - Overview
Exhibit 137: Johnson and Johnson - Business segments
Exhibit 138: Johnson and Johnson - Key news
Exhibit 139: Johnson and Johnson - Key offerings
Exhibit 140: Johnson and Johnson - Segment focus
10.12 Siemens Healthineers AG
Exhibit 141: Siemens Healthineers AG - Overview
Exhibit 142: Siemens Healthineers AG - Business segments
Exhibit 143: Siemens Healthineers AG - Key news
Exhibit 144: Siemens Healthineers AG - Key offerings
Exhibit 145: Siemens Healthineers AG - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 146: Inclusions checklist
Exhibit 147: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 148: Currency conversion rates for US$
11.4 Research methodology
Exhibit 149: Research methodology
Exhibit 150: Validation techniques employed for market sizing
Exhibit 151: Information sources
11.5 List of abbreviations
Exhibit 152: List of abbreviations
List of ExhibitsExhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Blood glucose - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Blood glucose - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Blood glucose - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Blood glucose - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Infectious disease - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Infectious disease - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Infectious disease - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Infectious disease - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Cardiometabolic - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Cardiometabolic - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Cardiometabolic - Year-over-year growth 2021-2026 (%)
Exhibits 40: Chart on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
Exhibits 41: Data Table on Pregnancy and fertility - Market size and forecast 2021-2026 ($ million)
Exhibits 42: Chart on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
Exhibits 43: Data Table on Pregnancy and fertility - Year-over-year growth 2021-2026 (%)
Exhibits 44: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 45: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits 46: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits 48: Market opportunity by Application ($ million)
Exhibits 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 52: Chart on Geographic comparison
Exhibits 53: Data Table on Geographic comparison
Exhibits 54: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 82: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 83: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 86: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 87: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 88: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 89: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 90: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 91: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 92: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 93: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 94: Market opportunity By Geographical Landscape ($ million)
Exhibits 95: Impact of drivers and challenges in 2021 and 2026
Exhibits 96: Overview on Criticality of inputs and Factors of differentiation
Exhibits 97: Overview on factors of disruption
Exhibits 98: Impact of key risks on business
Exhibits 99: Vendors covered
Exhibits 100: Matrix on vendor position and classification
Exhibits 101: Abbott Laboratories - Overview
Exhibits 102: Abbott Laboratories - Business segments
Exhibits 103: Abbott Laboratories - Key news
Exhibits 104: Abbott Laboratories - Key offerings
Exhibits 105: Abbott Laboratories - Segment focus
Exhibits 106: Atomo Diagnostics Ltd. - Overview
Exhibits 107: Atomo Diagnostics Ltd. - Product / Service
Exhibits 108: Atomo Diagnostics Ltd. - Key offerings
Exhibits 109: Becton Dickinson and Co. - Overview
Exhibits 110: Becton Dickinson and Co. - Business segments
Exhibits 111: Becton Dickinson and Co. - Key news
Exhibits 112: Becton Dickinson and Co. - Key offerings
Exhibits 113: Becton Dickinson and Co. - Segment focus
Exhibits 114: bioMerieux SA - Overview
Exhibits 115: bioMerieux SA - Business segments
Exhibits 116: bioMerieux SA - Key offerings
Exhibits 117: bioMerieux SA - Segment focus
Exhibits 118: Cardinal Health Inc. - Overview
Exhibits 119: Cardinal Health Inc. - Business segments
Exhibits 120: Cardinal Health Inc. - Key news
Exhibits 121: Cardinal Health Inc. - Key offerings
Exhibits 122: Cardinal Health Inc. - Segment focus
Exhibits 123: Chembio Diagnostics Inc. - Overview
Exhibits 124: Chembio Diagnostics Inc. - Product / Service
Exhibits 125: Chembio Diagnostics Inc. - Key offerings
Exhibits 126: Danaher Corp. - Overview
Exhibits 127: Danaher Corp. - Business segments
Exhibits 128: Danaher Corp. - Key news
Exhibits 129: Danaher Corp. - Key offerings
Exhibits 130: Danaher Corp. - Segment focus
Exhibits 131: F. Hoffmann La Roche Ltd. - Overview
Exhibits 132: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 133: F. Hoffmann La Roche Ltd. - Key news
Exhibits 134: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 135: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 136: Johnson and Johnson - Overview
Exhibits 137: Johnson and Johnson - Business segments
Exhibits 138: Johnson and Johnson - Key news
Exhibits 139: Johnson and Johnson - Key offerings
Exhibits 140: Johnson and Johnson - Segment focus
Exhibits 141: Siemens Healthineers AG - Overview
Exhibits 142: Siemens Healthineers AG - Business segments
Exhibits 143: Siemens Healthineers AG - Key news
Exhibits 144: Siemens Healthineers AG - Key offerings
Exhibits 145: Siemens Healthineers AG - Segment focus
Exhibits 146: Inclusions checklist
Exhibits 147: Exclusions checklist
Exhibits 148: Currency conversion rates for US$
Exhibits 149: Research methodology
Exhibits 150: Validation techniques employed for market sizing
Exhibits 151: Information sources
Exhibits 152: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global rapid diagnostics market: Abbott Laboratories, Atomo Diagnostics Ltd., Becton Dickinson and Co., bioMerieux SA, Cardinal Health Inc., Chembio Diagnostics Inc., DAAN Gene Co. Ltd., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GlySens Inc., Johnson, and Johnson, Meridian Bioscience Inc., NanoRepro AG, Quidel Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech Plc, Wuhan EasyDiagnosis Biomedicine Co. Ltd, and OraSure Technologies Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the growing presence of OEMs.`
According to the report, one of the major drivers for this market is the increasing incidence of chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Atomo Diagnostics Ltd.
- Becton Dickinson and Co.
- bioMerieux SA
- Cardinal Health Inc.
- Chembio Diagnostics Inc.
- DAAN Gene Co. Ltd.
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- GlySens Inc.
- Johnson and Johnson
- Meridian Bioscience Inc.
- NanoRepro AG
- Quidel Corp.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
- Wuhan EasyDiagnosis Biomedicine Co. Ltd
- OraSure Technologies Inc.
